Sarcopenia is a known independent prognostic factor for decreased survival in patients with head and neck cancer, yet its importance for the growing number of younger patients diagnosed with human papillomavirus (HPV) positive oropharyngeal carcinoma (OPC+) has not been established. This systematic literature review aimed to determine the prevalence and impact of computed tomography (CT)-defined sarcopenia on survival outcomes for adult patients (>18 years) with OPC+ undergoing any treatment modality. Prospective studies were searched for using PubMed, Embase, CENTRAL, CINAHL and Web of Science up until and including February 2022. Bias was assessed using the Quality In Prognosis Studies (QUIPS) tool, and certainty of evidence using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system. In total, nine studies (total pooled patients with OPC+ n=744) were identified and included in this review; two at low, six at moderate, and one at high risk of bias. All studies varied in sarcopenia assessment methods and skeletal muscle index threshold cut-off values. These studies demonstrated the cumulative prevalence of sarcopenia for patients with OPC+ to be 42.9% (95%CI: 37.8-47.9). While overall survival (three studies, n=253) and progression-free survival (one study, n=117) was lower in sarcopenic patients with OPC+, this was not statistically significant. GRADE certainty of evidence for impact of pre-treatment sarcopenia on overall survival was low and progression-free survival very low. Although these studies showed there to be a high prevalence of pre-treatment sarcopenia in patients with OPC+, which may decrease survival, the impact on progression-free survival is very uncertain. Further, high quality research utilizing consistent sarcopenia definitions and assessment methods that are conducted specifically in OPC+ is required to strengthen evidence certainty and determine if sarcopenia is an independent prognostic factor for this population.
Purpose: Human papillomavirus (HPV) is now the primary cause of oropharyngeal head and neck cancer (OPC) worldwide; yet limited research has examined the effect of HPV-positive status (OPC+) on nutrition outcomes. This study aims to determine the impact of HPV status on nutritional outcomes for adult patients with OPC undergoing any treatment modality. Methods: A systematic literature review was conducted up to and including July 2021 of PubMed, Embase, CENTRAL, CINAHL, and Web of Science to identify studies conducted in adults (>18 years) with known OPC reporting on any outcome(s) related to nutrition, according to HPV status (OPC+ versus OPC−). Bias was assessed using QUIPS tool, with certainty of evidence assessed using GRADE system. Results: Six studies (total n = 635) all at moderate-high risk of bias were included. Three studies reported on weight change (n = 255), three feeding tube dependency (n = 380), three feeding tube timing of placement (prophylactic or reactive) and/or utilisation (n = 255), two nutritional (energy and/or protein) intake (n = 230), and one nutritional status (n = 83). Patients with OPC+ may experience greater weight loss, may have higher utilisation of reactive feeding tubes (both GRADE low certainty, downgraded due to serious bias and imprecision), and may have lower feeding tube dependency rates (GRADE low certainty, downgraded due to serious bias and inconsistency) versus OPC− . It is uncertain whether nutritional intake and nutritional status differed between populations (GRADE very low certainty, downgraded due to serious bias and very serious imprecision). Conclusion: Further, high-quality research is needed to understand optimal nutritional care practices for patients with OPC + to achieve positive health outcomes into survivorship.